147 related articles for article (PubMed ID: 10608851)
1. X-ray crystal structure of human dopamine sulfotransferase, SULT1A3. Molecular modeling and quantitative structure-activity relationship analysis demonstrate a molecular basis for sulfotransferase substrate specificity.
Dajani R; Cleasby A; Neu M; Wonacott AJ; Jhoti H; Hood AM; Modi S; Hersey A; Taskinen J; Cooke RM; Manchee GR; Coughtrie MW
J Biol Chem; 1999 Dec; 274(53):37862-8. PubMed ID: 10608851
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of human catecholamine sulfotransferase.
Bidwell LM; McManus ME; Gaedigk A; Kakuta Y; Negishi M; Pedersen L; Martin JL
J Mol Biol; 1999 Oct; 293(3):521-30. PubMed ID: 10543947
[TBL] [Abstract][Full Text] [Related]
3. A single amino acid, glu146, governs the substrate specificity of a human dopamine sulfotransferase, SULT1A3.
Dajani R; Hood AM; Coughtrie MW
Mol Pharmacol; 1998 Dec; 54(6):942-8. PubMed ID: 9855620
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the substrate specificity of human sulfotransferases SULT1A1 and SULT1A3: site-directed mutagenesis and kinetic studies.
Brix LA; Barnett AC; Duggleby RG; Leggett B; McManus ME
Biochemistry; 1999 Aug; 38(32):10474-9. PubMed ID: 10441143
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of human sulfotransferase SULT1A3 in complex with dopamine and 3'-phosphoadenosine 5'-phosphate.
Lu JH; Li HT; Liu MC; Zhang JP; Li M; An XM; Chang WR
Biochem Biophys Res Commun; 2005 Sep; 335(2):417-23. PubMed ID: 16083857
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of mSULT1D1, a mouse catecholamine sulfotransferase.
Teramoto T; Sakakibara Y; Inada K; Kurogi K; Liu MC; Suiko M; Kimura M; Kakuta Y
FEBS Lett; 2008 Nov; 582(28):3909-14. PubMed ID: 18977225
[TBL] [Abstract][Full Text] [Related]
7. CoMFA modeling of enzyme kinetics: K(m) values for sulfation of diverse phenolic substrates by human catecholamine sulfotransferase SULT1A3.
Sipilä J; Hood AM; Coughtrie MW; Taskinen J
J Chem Inf Comput Sci; 2003; 43(5):1563-9. PubMed ID: 14502490
[TBL] [Abstract][Full Text] [Related]
8. Structure-function relationships in the stereospecific and manganese-dependent 3,4-dihydroxyphenylalanine/tyrosine-sulfating activity of human monoamine-form phenol sulfotransferase, SULT1A3.
Pai TG; Oxendine I; Sugahara T; Suiko M; Sakakibara Y; Liu MC
J Biol Chem; 2003 Jan; 278(3):1525-32. PubMed ID: 12424257
[TBL] [Abstract][Full Text] [Related]
9. Lack of enantioselectivity in the SULT1A3-catalyzed sulfoconjugation of normetanephrine enantiomers: an in vitro and computational study.
Grouzmann E; Gualtierotti JB; Gerber-Lemaire S; Abid K; Brakch N; Pedretti A; Testa B; Vistoli G
Chirality; 2013 Jan; 25(1):28-34. PubMed ID: 23008099
[TBL] [Abstract][Full Text] [Related]
10. A single mutation converts the nucleotide specificity of phenol sulfotransferase from PAP to AMP.
Hsiao YS; Yang YS
Biochemistry; 2002 Oct; 41(43):12959-66. PubMed ID: 12390022
[TBL] [Abstract][Full Text] [Related]
11. Carboxyl residues in the active site of human phenol sulfotransferase (SULT1A1).
Chen G; Rabjohn PA; York JL; Wooldridge C; Zhang D; Falany CN; Radominska-Pandya A
Biochemistry; 2000 Dec; 39(51):16000-7. PubMed ID: 11123927
[TBL] [Abstract][Full Text] [Related]
12. Kinetic properties of human dopamine sulfotransferase (SULT1A3) expressed in prokaryotic and eukaryotic systems: comparison with the recombinant enzyme purified from Escherichia coli.
Dajani R; Sharp S; Graham S; Bethell SS; Cooke RM; Jamieson DJ; Coughtrie MW
Protein Expr Purif; 1999 Jun; 16(1):11-8. PubMed ID: 10336855
[TBL] [Abstract][Full Text] [Related]
13. Effects of human SULT1A3/SULT1A4 genetic polymorphisms on the sulfation of acetaminophen and opioid drugs by the cytosolic sulfotransferase SULT1A3.
Bairam AF; Rasool MI; Alherz FA; Abunnaja MS; El Daibani AA; Kurogi K; Liu MC
Arch Biochem Biophys; 2018 Jun; 648():44-52. PubMed ID: 29705271
[TBL] [Abstract][Full Text] [Related]
14. Sulfation of ritodrine by the human cytosolic sulfotransferases (SULTs): Effects of SULT1A3 genetic polymorphism.
Hui Y; Liu MC
Eur J Pharmacol; 2015 Aug; 761():125-9. PubMed ID: 25941087
[TBL] [Abstract][Full Text] [Related]
15. Sulfation of catecholamines and serotonin by SULT1A3 allozymes.
Bairam AF; Rasool MI; Alherz FA; Abunnaja MS; El Daibani AA; Gohal SA; Kurogi K; Sakakibara Y; Suiko M; Liu MC
Biochem Pharmacol; 2018 May; 151():104-113. PubMed ID: 29524394
[TBL] [Abstract][Full Text] [Related]
16. Role of Conformational Dynamics of Sulfotransferases SULT1A1 and SULT1A3 in Substrate Specificity.
Toth D; Dudas B; Miteva MA; Balog E
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069221
[TBL] [Abstract][Full Text] [Related]
17. Aggresome formation and pharmacogenetics: sulfotransferase 1A3 as a model system.
Wang L; Yee VC; Weinshilboum RM
Biochem Biophys Res Commun; 2004 Dec; 325(2):426-33. PubMed ID: 15530410
[TBL] [Abstract][Full Text] [Related]
18. Impact of SULT1A3/SULT1A4 genetic polymorphisms on the sulfation of phenylephrine and salbutamol by human SULT1A3 allozymes.
Bairam AF; Rasool MI; Alherz FA; Abunnaja MS; El Daibani AA; Gohal SA; Alatwi ES; Kurogi K; Liu MC
Pharmacogenet Genomics; 2019 Jul; 29(5):99-105. PubMed ID: 31145702
[TBL] [Abstract][Full Text] [Related]
19. Active site mutations and substrate inhibition in human sulfotransferase 1A1 and 1A3.
Barnett AC; Tsvetanov S; Gamage N; Martin JL; Duggleby RG; McManus ME
J Biol Chem; 2004 Apr; 279(18):18799-805. PubMed ID: 14871892
[TBL] [Abstract][Full Text] [Related]
20. A structural and biochemical basis for PAPS-independent sulfuryl transfer by aryl sulfotransferase from uropathogenic Escherichia coli.
Malojcić G; Owen RL; Grimshaw JP; Brozzo MS; Dreher-Teo H; Glockshuber R
Proc Natl Acad Sci U S A; 2008 Dec; 105(49):19217-22. PubMed ID: 19036922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
